knowledge -WSS

knowledge

author：entertainment 2025-10-02 21:06:09 - browse：83

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Zapping the brain for stroke rehab: Pivotal clinical trial begins

focus

hotspot

WSS

Germany receives 178 compensation applications from gay servicepeople over discrimination

Astronauts get first look at the spacecraft that will fly them around the moon

Home health providers sue Medicare over payment cuts

In venture capital firm's success, lessons for turning crisis into profit

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

knowledge

leisure time

The high cost of giving birth even with insurance

Biden praises World Series champion Astros for impact off the field during White House celebration

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ACA's risk program benefits Blue Cross Blue Shield insurers

Alkermes shareholders re

In venture capital firm's success, lessons for turning crisis into profit

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Discs beat pads, tampons for heavy menstrual flow, new study shows

Medical leaders decry Supreme Court decision on affirmative action

Astronauts get first look at the spacecraft that will fly them around the moon

focus

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Home health providers sue Medicare over payment cuts

Teachers share how revamped forgiveness program helped with their student loans

‘The Bear’ and hospitality in hospitals

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

focus

hotspot

hotspot

explore